{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T01:58:10Z","timestamp":1776131890927,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002975","name":"Dainippon Sumitomo Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002975","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Pharmacokinetics"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.dmpk.2020.09.005","type":"journal-article","created":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T12:47:52Z","timestamp":1601470072000},"page":"563-570","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pharmacokinetics, safety and metabolite profiling of minesapride, a novel 5-HT4 receptor partial agonist, in healthy elderly and young subjects"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9555-6057","authenticated-orcid":false,"given":"Tatsuto","family":"Hamatani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuta","family":"Shibue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoyuki","family":"Sawada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Takagaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayo","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Nakada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0176-7775","authenticated-orcid":false,"given":"Hiroyoshi","family":"Kakuyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dmpk.2020.09.005_bib1","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2019.12.021","article-title":"Prevalence of Rome IV functional bowel disorders among adults in the United States, Canada, and the United Kingdom","author":"Palsson","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dmpk.2020.09.005_bib2","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1053\/j.gastro.2016.02.031","article-title":"Bowel disorders","volume":"150","author":"Lacy","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dmpk.2020.09.005_bib3","article-title":"Irritable bowel syndrome","volume":"24","author":"Enck","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.dmpk.2020.09.005_bib4","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/j.1365-2036.2010.04273.x","article-title":"Systematic review: impact of constipation on quality of life in adults and children","volume":"31","author":"Belsey","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dmpk.2020.09.005_bib5","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1007\/s10620-011-1639-5","article-title":"Impact of chronic constipation on health-related quality of life, work productivity, and healthcare resource use: an analysis of the National Health and Wellness Survey","volume":"56","author":"Sun","year":"2011","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dmpk.2020.09.005_bib6","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1053\/j.gastro.2006.11.002","article-title":"The serotonin signaling system: from basic understanding to drug development for functional GI disorders","volume":"132","author":"Gershon","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dmpk.2020.09.005_bib7","series-title":"Rome IV: functional gastrointestinal disorders; disorder of gut-brain interaction","year":"2016"},{"key":"10.1016\/j.dmpk.2020.09.005_bib8","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.cgh.2019.07.007","article-title":"Relative efficacy of tegaserod in a systematic review and network meta-analysis of licensed therapies for irritable bowel syndrome with constipation","volume":"18","author":"Black","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dmpk.2020.09.005_bib9","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S2468-1253(19)30246-8","article-title":"Efficacy of drugs in chronic idiopathic constipation: a systematic review and network meta-analysis","volume":"4","author":"Luthra","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.dmpk.2020.09.005_bib10","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ejphar.2018.02.005","article-title":"DSP-6952, a novel partial 5-HT4 receptor agonist, inhibits visceral hypersensitivity and ameliorates gastrointestinal dysfunction in experimental animals","volume":"826","author":"Mine","year":"2018","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.dmpk.2020.09.005_bib11","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/cpdd.731","article-title":"A\u00a0three-part phase 1 study to investigate the safety, tolerability, pharmacokinetics, and pharmacodynamics of DSP-6952 in healthy Japanese subjects and those with \u22643 spontaneous bowel movements per week","volume":"9","author":"Yumizaki","year":"2020","journal-title":"Clin Pharmacol Drug Dev"},{"key":"10.1016\/j.dmpk.2020.09.005_bib12","doi-asserted-by":"crossref","unstructured":"Hamatani T, Noda N, Takagaki T, Yodo Y, Kawai H, Kakuyama H, et\u00a0al. Thorough QT\/QTc study shows that a novel 5-HT4 receptor partial agonist minesapride has no effect on QT prolongation. Clin Pharmacol Drug Dev; https:\/\/doi.org\/10.1002\/cpdd.778.","DOI":"10.1002\/cpdd.778"},{"key":"10.1016\/j.dmpk.2020.09.005_bib13","doi-asserted-by":"crossref","unstructured":"Fukudo S, Nakamura M, Hamatani T, Kazumori K, Miwa H. Efficacy and safety of 5-HT4 receptor agonist minesapride for irritable bowel syndrome with constipation in a randomized controlled trial. Clin Gastroenterol Hepatol, https:\/\/doi.org\/10.1016\/j.cgh.2020.03.019.","DOI":"10.1016\/j.cgh.2020.03.019"},{"key":"10.1016\/j.dmpk.2020.09.005_bib14","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.cgh.2012.02.029","article-title":"Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis","volume":"10","author":"Lovell","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dmpk.2020.09.005_bib15","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1038\/ajg.2011.164","article-title":"Prevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review and meta-analysis","volume":"106","author":"Suares","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dmpk.2020.09.005_bib16","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/ajg.2011.349","article-title":"Chronic constipation in the elderly","volume":"107","author":"Gallegos-Orozco","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dmpk.2020.09.005_bib17","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1021\/js970486q","article-title":"Plasma-pooling methods to increase throughput for in\u00a0vivo pharmacokinetic screening","volume":"87","author":"Hop","year":"1998","journal-title":"J\u00a0Pharmacol Sci"},{"key":"10.1016\/j.dmpk.2020.09.005_bib18","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/clpt.1981.56","article-title":"Determination of mean valproic acid serum level by assay of a single pooled sample","volume":"29","author":"Hamilton","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.dmpk.2020.09.005_bib20","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1124\/pr.56.2.4","article-title":"Aging biology and geriatric clinical pharmacology","volume":"56","author":"McLean","year":"2004","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.dmpk.2020.09.005_bib21","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1136\/hrt.79.5.493","article-title":"Circadian rhythm of the signal averaged electrocardiogram and its relation to heart rate variability in healthy subjects","volume":"79","author":"Nakagawa","year":"1998","journal-title":"Heart"},{"key":"10.1016\/j.dmpk.2020.09.005_bib22","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1093\/cvr\/24.3.210","article-title":"Circadian variation of heart rate variability","volume":"24","author":"Malpas","year":"1990","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.dmpk.2020.09.005_bib24","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejphar.2018.02.037","article-title":"The in\u00a0vitro pharmacology and non-clinical cardiovascular safety studies of a novel 5-HT4 receptor agonist, DSP-6952","volume":"826","author":"Tsubouchi","year":"2018","journal-title":"Eur J Pharmacol"}],"container-title":["Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347436720304183?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347436720304183?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:55:43Z","timestamp":1761162943000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347436720304183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S1347436720304183"],"URL":"https:\/\/doi.org\/10.1016\/j.dmpk.2020.09.005","relation":{},"ISSN":["1347-4367"],"issn-type":[{"value":"1347-4367","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacokinetics, safety and metabolite profiling of minesapride, a novel 5-HT4 receptor partial agonist, in healthy elderly and young subjects","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Pharmacokinetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmpk.2020.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}